Cutler Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Cutler Group’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-250	Closed	-$2K	–	5482
2017 Q4	$2K	Sell	250 -5,325	-96%	-$239K	﹤0.01%	4267
2017 Q3	$11K	Buy	5,575 +2,650	+91%	+$447K	﹤0.01%	3761
2017 Q2	$138K	Buy	2,925 +925	+46%	+$162K	0.01%	1595
2017 Q1	$43K	Sell	2,000 -2,625	-57%	-$275K	﹤0.01%	2573
2016 Q4	$9K	Sell	4,625 -4,388	-49%	-$462K	﹤0.01%	4367
2016 Q3	$75K	Buy	+9,013	New	+$1.08M	﹤0.01%	2069
2016 Q2	–	Sell	-625	Closed	-$2K	–	7489
2016 Q1	$2K	Sell	625 -163	-21%	-$17.4K	﹤0.01%	5730
2015 Q4	$35K	Buy	+788	New	+$103K	﹤0.01%	2846

Other funds holding SIOX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TVWM

Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Cutler Group's SIOX Position: Q1 2021 in Review

Cutler Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2021, closing a stake of 2,000 shares — an estimated $5K sold.

Cutler Group first reported a position in SIOX in Q4 2015 and held it in 16 quarters. The position peaked at $510K in Q2 2017. 56 funds tracked by Wall St. Rank hold SIOX as of Q1 2021.

Cutler Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Cutler Group sold 2,000 Sio Gene Therapies Inc. Common Stock shares in Q1 2021, an estimated $5K.
Cutler Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 16 quarters.
Cutler Group's Sio Gene Therapies Inc. Common Stock position peaked at $510K in Q2 2017.
56 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.